October 4, 2023
Adaptive clinical trial designs have become increasingly popular among developers and investors due to the many...
Read article
September 29, 2023
In the ever-changing field of clinical trial design, there is often a need to evaluate design options quickly and...
Read article
March 13, 2023
Many industries have long since adopted the practice of modeling and simulating experimental scenarios. And despite...
Read article
February 3, 2023
For clinical development and research and development teams, the Pareto Frontier can perform two functions. Let’s take...
Read article
January 27, 2023
Should your clinical trial be adaptive? Trials that include a prospectively planned modification based on an interim...
Read article
January 4, 2023
Returning to Cytel after the winter holidays, I am excited to begin a year that will likely prove memorable for both my...
Read article
December 27, 2022
Bayesian methods have been playing a key role in transforming clinical research, providing a variety of new...
Read article
December 21, 2022
Perspectives on Enquiry and Evidence features two recurring interview series: Our new Industry Voices series, in which...
Read article
December 19, 2022
Adaptive trial designs – that is, trials that include a prospectively planned modification based on an interim analysis...
Read article
December 16, 2022
Bayesian methods have been playing a key role in transforming clinical research, and Bayesian topics are frequently...
Read article
December 2, 2022
For 35 years, Cytel’s scientific rigor and operational excellence have enabled biotech and pharmaceutical companies to...
Read article
November 29, 2022
Bayesian methods have continuously played a key role in transforming clinical research in therapeutic areas such as...
Read article
October 24, 2022
On the occasion of Cytel’s 35th anniversary, co-founder Professor Cyrus Mehta sits down with Dr. Esha Senchaudhuri to...
Read article
October 18, 2022
On the occasion of Cytel’s 35th anniversary, co-founder Professor Nitin Patel sits down with Dr. Esha Senchaudhuri to...
Read article
October 11, 2022
On the occasion of Cytel’s 35th anniversary, our CEO Joshua Schultz sits down with Dr. Esha Senchaudhuri to discuss the...
Read article
October 4, 2022
Integrated Nested Laplacian Approximations (or INLA) are now starting to be used by statisticians as a key tool for...
Read article
September 23, 2022
Adaptive trial designs – that is, trials that include a prospectively planned modification based on an interim analysis...
Read article
September 12, 2022
In clinical trials, patient enrollment is often staggered, with data collected sequentially. When designing a clinical...
Read article
October 22, 2021
Currently, there are many treatment options for Cancer such as, Immunotherapy, Radiation Therapy, Chemotherapy etc. If...
Read article
October 6, 2021
Master Protocols are advanced and innovative clinical trial designs that can evaluate multiple therapies and disease...
Read article
October 1, 2021
The COVID-19 pandemic elevated the challenge of designing and executing clinical trials within a substantially...
Read article
September 29, 2021
While there is a plethora of rare diseases, some 7000 diseases and counting, one needs to consider the statutory...
Read article
September 24, 2021
We may be familiar with adaptive designs, but their complexity has made them difficult to implement and their benefits...
Read article
June 30, 2021
When Cyrus Mehta introduced the Promising Zone Design over a decade ago, the new statistical method not only...
Read article
June 23, 2021
Much of the discussion about clinical trial design considers methods to optimize performance characteristics and...
Read article
June 18, 2021
Next week’s PSI Conference will feature Dr. Yannis Jemiai speaking on the use of Scoring Functions in the re-imagined...
Read article
June 15, 2021
Ten years ago, a seminal paper published by Cytel Founder Cyrus Mehta, introduced the Promising Zone Design to...
Read article
June 9, 2021
When selecting clinical trial designs, how many design options should a sponsor explore? Would a sponsor feel more...
Read article
June 2, 2021
For many decades the Pareto Frontier has been employed by actors in the private sector to evaluate and understand the...
Read article
May 14, 2021
When developing clinical strategy, applying familiar business principles to the specific requirements of clinical...
Read article
April 28, 2021
Recently, Cytel co-founder Professor Cyrus Mehta noted that, “Clinical trial design selection is too much like an art,...
Read article
April 23, 2021
The urgent need to discover and assess the efficacy and safety of COVID-19 vaccine candidates will affect the future...
Read article
January 26, 2021
Bayesian models offer a flexible way of incorporating historical controls in the analysis of trial data (whether single...
Read article
December 17, 2020
As Chief Scientific Officer, Dr. Yannis Jemiai plays a pivotal role in maintaining Cytel’s well-established reputation...
Read article
December 16, 2020
As we prepare to close the door on 2020, we asked Pantelis Vlachos, Principal/Strategic Consultant for Cytel, to share...
Read article
December 15, 2020
When designing clinical trials, biostatisticians and clinical development teams are often faced with a conundrum. Given...
Read article
December 9, 2020
As a part of Cytel’s Advanced Design Framework, a new Framework for the statistical design of clinical trials, Cytel...
Read article
December 3, 2020
Increasing Clinical Development Productivity Using Statistics and Cloud-Computing The need for Re-imagining Clinical...
Read article
November 18, 2020
The current state of the clinical trials industry faces a challenge that was only hypothetical three or four years ago....
Read article
November 17, 2020
As a part of Cytel’s "New Horizons Webinar Series", Alind Gupta, Senior Data Scientist, presents case studies from his...
Read article
November 16, 2020
MUCE is a Bayesian solution for cohort expansion trials where multiple dose(s) and multiple indication(s) are tested in...
Read article
November 11, 2020
The widespread use of cloud-computing has altered the clinical trial design process. Whereas three or four years ago,...
Read article
November 4, 2020
Cytel has recently revealed its Advanced Design Framework, a method developed by Cytel’s thought leaders that draws on...
Read article
October 29, 2020
Cytel has recently revealed its Advanced Design Framework, a method developed by Cytel’s thought leaders that draws on...
Read article
October 21, 2020
Cytel has recently revealed its Advanced Design Framework, a method developed by Cytel’s thought-leaders after a decade...
Read article
October 15, 2020
For over a decade, advanced trial design techniques have promised efficient trials with accelerated timelines,...
Read article
October 1, 2020
Methods involving Group Sequential Designs are one of the earliest deviations from a traditional two-arm clinical trial...
Read article
September 29, 2020
Innovation in trial designs are offering new routes forward for organizations of any size. They are now also aligned...
Read article
September 9, 2020
Cytel’s co-founder, Nitin Patel, conducted a webinar on designing clinical trials from a program-level perspective. His...
Read article
August 26, 2020
As Chief Scientific Officer, Dr. Yannis Jemiai plays a pivotal role in maintaining Cytel’s well-established reputation...
Read article
August 25, 2020
It is important to take a strategic approach to clinical development in order to minimize the potential for Phase 3...
Read article
August 12, 2020
Cytel’s Biostatistics and Statistical Programming team provides integrated solutions, by blending the expertise of...
Read article
July 13, 2020
Cytel is hosting a complimentary webinar series that introduces biostatisticians and other members of the development...
Read article
July 7, 2020
Having its roots in the seminar rooms of the Dana Farber Cancer Institute, Cytel has a long record of establishing new...
Read article
April 29, 2020
In our previous blog, we spoke with Alind Gupta, who works as a Machine Learning Researcher at Cytel in Canada. The...
Read article
April 20, 2020
Cytel is hosting a webinar on Transparent Machine Learning in Oncology, on April 21, 2020. Our speaker, Alind Gupta,...
Read article
March 31, 2020
Since 1953, when the discovery of the structure of DNA was made, we have seen great advancements in genomics....
Read article
February 20, 2020
It is widely acknowledged among drug developers that one of their most important assets is the data generated during...
Read article
January 30, 2020
The Cytel Trial Design Innovations (CTDI) Webinar Series recently hosted a webinar on designing event-based studies....
Read article
January 16, 2020
January’s Cytel Trial Design Innovations (CTDI) Webinar Series will feature Biostatistician and pioneering Bayesian...
Read article
January 8, 2020
In clinical development, data is the vital ‘foundation’ that supports your programs. To successfully bring a promising...
Read article
November 5, 2019
Cytel is delighted to have Kannan Natarajan speaking at the “Complex Innovative Trial Design Symposium and East User...
Read article
November 12, 2018
In this blog, we talk with Robert Greene, Founder and President of the HungerNDThirst Foundation, about his upcoming...
Read article
October 23, 2018
Cytel data scientists apply advanced statistical techniques including predictive modeling of biological processes and...
Read article
October 5, 2018
We are delighted that Stephen Senn will be joining us at the EUGM on November 14th and 15th in Darmstadt, Germany. In...
Read article
September 27, 2018
In this blog, we talk with Heiko Götte, Senior Expert Biostatistician at Merck about his upcoming presentation at...
Read article
September 20, 2018
At Cytel we believe that expert statistical input has the power to shape the future of clinical development: de-risking...
Read article
August 23, 2018
Cytel has grown significantly over the last 30 years, with operations across North America, Europe, and India. All of...
Read article
August 15, 2018
Cytel’s 7th East User Group Meeting (EUGM) will take place on November 14 & 15, 2018 at Merck in Darmstadt, Germany,...
Read article
July 24, 2018
At Cytel our strategic consulting team works on a wide range of projects including: Identifying the best clinical trial...
Read article
July 3, 2018
It’s shaping up to be a busy year for Cytel’s software development team with a number of upgrades and planned launches...
Read article
July 2, 2018
A number of the Cytel team were in Amsterdam, 3rd- 6th June 2018 for the PSI Conference. This year’s conference was...
Read article
May 23, 2018
Our Industry Voices series showcases our clients’ innovative work and breakthrough therapeutics in oncologic...
Read article
May 16, 2018
Our Industry Voices series showcases our clients’ innovative work and breakthrough therapeutics in oncologic...
Read article
May 9, 2018
As we prepare to head to ASCO in under a month's time, we are pleased to share a new ebook that showcases some key...
Read article
February 28, 2018
There is a consensus in the industry that data on rare diseases is limited, incomplete, and difficult to find or...
Read article
February 13, 2018
Our strategic consulting team work on projects such as: Identifying the best clinical trial design, implementing...
Read article
October 31, 2017
As part of Cytel's new Trial Innovations Webinar Series, Pat Mitchell, Statistical Science Director at AstraZeneca...
Read article
October 18, 2017
Cytel's new Trial Innovations Webinar Series provides a platform for the most promising new statistical approaches...
Read article
July 26, 2017
Sadly, clinical development of anti-cancer therapeutics faces particularly high rates of failure, even in the context...
Read article
July 11, 2017
The Adaptive Designs and Multiple Testing Procedures Workshop (ADMTP), the first joint meeting of the Adaptive Designs...
Read article
July 6, 2017
By Esha Senchaudhuri The ethical benefits of adaptive clinical trials have been widely acclaimed: higher prospects for...
Read article
May 22, 2017
James (Jim) Bolognese, Senior Director, Strategic Consulting, Clinical Services at Cytel Inc. was named a 2017 fellow...
Read article
April 25, 2017
At a recent conference Adam Hamm, Director Biostatistics at Cytel, presented his thoughts on Best Practices and...
Read article
April 11, 2017
In a January 2017 paper (1), the FDA reviewed 22 case studies where promising Phase 2 trials did not result in...
Read article
March 29, 2017
With an increasing interest in platform designs and other innovative designs that involve multiple comparisons over...
Read article
October 7, 2016
Adaptive designs have the potential to accelerate clinical development, and improve the probability of trial success....
Read article
September 29, 2016
A paper "Best practices case studies for 'less well-understood' Adaptive designs", has been published by the DIA...
Read article
July 18, 2016
In order for adaptive designs to reach their potential, it’s critical that knowledge is effectively dissemirnated...
Read article
April 28, 2016
Adaptive Designs in Practice: Interview with NIHR Research Fellow Munya Dimairo NIHR and University of Sheffield...
Read article
April 22, 2016
FDA draft guidance on “Co development of two or more unmarketed investigational drugs for use in combination” notes...
Read article
March 11, 2016
There has been increasing interest in multi-arm multi-stage trials with treatment selection and sample size...
Read article
March 3, 2016
'The aim of a discussion should not be victory but progress.' This principle, expressed by the French essayist Joseph...
Read article
October 1, 2015
This week marks the sixth annual American Conference on Pharmacometrics, held this year in Crystal City, VA. Situated...
Read article
September 17, 2015
Most people familiar with adaptive clinical trial designs are familiar with those statistical designs that reject the...
Read article
June 26, 2015
Powering a trial for superiority can be financially risky. In some instances it may also prove unnecessary.
Read article
June 11, 2015
When the FDA first began to require pharmaceuticals to perform cardiovascular outcome trials to establish the safety of...
Read article
May 20, 2015
Seamless adaptive clinical trials have gained popularity for reducing the projected time it takes to complete the...
Read article
April 30, 2015
Adaptive financing (not to be confused with adaptive licensing) explores how biotechs, pharmaceuticals and potential...
Read article
April 23, 2015
Last week the Cytel Blog discussed the benefits of using the Adaptive Maximizing Design [AM Design] for dose-finding...
Read article
April 16, 2015
When testing certain types of new drugs it is known in advance that the adverse side-effects of the medication will...
Read article
March 20, 2015
Sometimes a new candidate drug for a pediatric study has already been tested on adults for safety and efficacy. We know...
Read article
January 29, 2015
February 2015 marks the five year anniversary of the FDA’s Guidance on Adaptive Design Clinical Trials for Drug and...
Read article
December 18, 2014
Earlier this week, we at Cytel enjoyed a riveting in-house discussion on the uses of Bayesian decision rules for...
Read article
November 12, 2014
Clinical utility functions provide Phase 2 trial sponsors with an intuitive metric by which to measure the quality of a...
Read article
September 4, 2014
Imagine if we were to count the number of possible reasons that investigators might have for monitoring a biomarker...
Read article
July 29, 2014
Adaptive designs are the unsurprising hot topic of this year’s Joint Statistical Meeting, which features over one...
Read article
July 8, 2014
The above graphic is from Cyrus Mehta's slides on 'Adaptive Population Enrichment for Oncology Trials with Time to...
Read article
June 5, 2014
Charles Liu, PhD, Cytel Statistician and Product Manager In the US, cancer is the most common cause of death after...
Read article
